Exagen INC Form 4 insider transactions

Kamal Adawi, CFO of Exagen Inc., sold shares of common stock on March 4, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Exagen Inc.'s CEO, John Aballi, acquired 9,804 shares of common stock through the Employee Stock Purchase Plan at a price of $1.91 per share on February 29, 2024, increasing his direct holdings to 600,788 shares.